Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1206.00
7.05 (0.59%) Dr. Reddy's Labs. - Quaterly Results
Date: 23-07-2026
The sales is pegged at Rs. 51366.00 millions for the June 2026 quarter. The mentioned figure indicates a decline of about -34.23% as against Rs. 78095.00 millions during the year-ago period.A radical decline of -86.33% was reported in the net profit of the company for the quarter ended June 2026 to Rs. 4047.00 millions from Rs. 29612.00 millions.The company reported a degrowth in operating Profit to 8878.00 millions from 42353.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 51366.00 | 78095.00 | -34.23 | 51366.00 | 78095.00 | -34.23 | 205328.00 | 231154.00 | -11.17 |
| Other Income | 4404.00 | 3983.00 | 10.57 | 4404.00 | 3983.00 | 10.57 | 16896.00 | 10034.00 | 68.39 |
| PBIDT | 8878.00 | 42353.00 | -79.04 | 8878.00 | 42353.00 | -79.04 | 56070.00 | 83852.00 | -33.13 |
| Interest | 731.00 | 192.00 | 280.73 | 731.00 | 192.00 | 280.73 | 1483.00 | 1099.00 | 34.94 |
| PBDT | 8147.00 | 42161.00 | -80.68 | 8147.00 | 42161.00 | -80.68 | 54587.00 | 82753.00 | -34.04 |
| Depreciation | 3177.00 | 2798.00 | 13.55 | 3177.00 | 2798.00 | 13.55 | 12074.00 | 10394.00 | 16.16 |
| PBT | 4970.00 | 39363.00 | -87.37 | 4970.00 | 39363.00 | -87.37 | 42513.00 | 72359.00 | -41.25 |
| TAX | 923.00 | 9751.00 | -90.53 | 923.00 | 9751.00 | -90.53 | 10316.00 | 18865.00 | -45.32 |
| Deferred Tax | 422.00 | 334.00 | 26.35 | 422.00 | 334.00 | 26.35 | 1139.00 | 960.00 | 18.65 |
| PAT | 4047.00 | 29612.00 | -86.33 | 4047.00 | 29612.00 | -86.33 | 32197.00 | 53494.00 | -39.81 |
| Equity | 835.00 | 835.00 | 0.00 | 835.00 | 835.00 | 0.00 | 835.00 | 834.00 | 0.12 |
| PBIDTM(%) | 17.28 | 54.23 | -68.13 | 17.28 | 54.23 | -68.13 | 27.31 | 36.28 | -24.72 |